All articles — 4008 total
TASK heads into the post-earnings tape with the most significant short-covering story it has seen in months. The clearest signal is the dramatic unwind in short positioning. Short interest peaked at nearly 17.6% of…
Lyell Immunopharma reported its Q1 2026 results after the close on May 6 — EPS of -$1.10 beat the -$2.19 consensus estimate, though revenue of $2,000 came in below the $4,400 estimate. The stock enters the week down 4%…
Tenaya Therapeutics reported Q1 2026 results just after Wednesday's close. The headline number landed on both sides of the ledger — EPS of -$0.09 missed the -$0.06 estimate, but revenue of $25 million crushed the $10…
HNST enters its Q1 2026 results — due after the bell tomorrow, May 7 — with short sellers in full retreat and the stock up 22% in a month, a notably charged setup for a sub-$4 name in personal care. The most compelling…
Context Therapeutics enters its Q1 2026 earnings release with short sellers having already made a decisive exit — and Q1 EPS just printed a beat, coming in at -$0.09 versus the -$0.12 estimate. Short interest has…
AGL heads into the post-earnings session having tripled from the canvas — and the Street's response is already turning cooler. The stock closed Tuesday at $26.74, up 149% over the past month. That recovery traces…
DoubleVerify Holdings is walking into its May 21 Q1 results with a split personality in positioning: short sellers adding exposure at the fastest pace in months, while options traders have swung to their most bullish…
PureCycle Technologies just beat Q1 estimates — and the shorts are barely flinching. The stock closed at $7.65 on Tuesday, up 8% on the week and 41% over the past month. Q1 EPS came in at -$0.21, beating the -$0.25…
Aeva Technologies heads into this week with a striking contrast: one of the most heavily shorted small-cap names in the sensor space, yet options traders are the least bearish they have been all year. The short…
ACV Auctions just reported its cleanest quarter yet — and the market responded by pushing the stock up 8% on the week before the earnings print even landed. The Q1 numbers, released after the close on May 6, came in…
Stem, Inc. just reported Q1 results into one of the most charged short-positioning setups it has seen all year. Q1 delivered a classic beat-miss split. EPS came in at -$2.22, better than the -$2.30 consensus. Revenue…
APA Corporation enters its May 7 Q1 results sitting in an unusual position: short sellers have been stepping back sharply, options traders are leaning constructive, and the Street — while not enthusiastic — has been…
Riley Exploration Permian heads into its May 7 earnings call with shorts in full retreat and options traders leaning firmly bullish — a combination that sharpens the stakes on tomorrow's print considerably. The…
Sable Offshore Corp. heads into its May 14 earnings call carrying the double weight of a highly shorted float and a cluster of fresh insider selling — a combination that makes the next print unusually charged. The…
Texas Pacific Land Corporation reported Q1 2026 results after the close on May 6, with a beat on earnings and a narrow miss on revenue arriving just as short interest hits its highest level in months — the most charged…
Shoals Technologies Group enters the post-earnings week with analysts upgrading price targets and the stock up 6% on the week — yet short sellers are quietly rebuilding, a tension worth watching closely. The Q1…
Great Elm Group dropped its fiscal Q3 2026 results after the bell on May 6, with an earnings call scheduled for May 7 — making this note land squarely in the eye of the storm. The headline numbers were rough. Q3 EPS…
Montauk Renewables heads into its May 7 earnings call having just printed a Q1 beat — and with short sellers in full retreat. The earnings story is the standout this week. Q1 revenue came in at $46.4M, ahead of the…
DoorDash heads into its post-earnings week with an uncomfortable combination: a stock down 3.4% over five days, short interest at a six-week high, and options traders the most defensively positioned they have been in…
Clover Health Investments enters this week with a striking contradiction: the stock has surged 52% over the past month, yet insiders have been selling into almost every uptick — and short sellers haven't budged. The…
